Chronic urticaria in a child affected by atopic dermatitis: effective treatment with omalizumab

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

(2018) T. Zuberbier et al.   ALLERGY

The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): statistical analysis plan

(2017) Tao Chen et al.   Trials

Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial

(2017) Susan Chan et al.   Trials

Omalizumab for atopic dermatitis: case series and a systematic review of the literature

(2016) Jesper Grønlund Holm et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Atopic Dermatitis in Children

(2015) Jonathan J. Lyons et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria

(2015) Tse Wen Chang et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Chronic Spontaneous Urticaria

(2013) Sarbjit S. Saini   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Immunologic Effects of Omalizumab in Children with Severe Refractory Atopic Dermatitis: A Randomized, Placebo-Controlled Clinical Trial

(2013) Shuba Rajashri Iyengar et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Pathophysiology of chronic urticaria

(2010) Lindsey A. Brodell et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Pathogenesis of chronic urticaria

(2009) A. P. Kaplan et al.   CLINICAL AND EXPERIMENTAL ALLERGY

New concepts in chronic urticaria

(2008) Becky M Vonakis et al.   CURRENT OPINION IN IMMUNOLOGY